Skip to content
HowShorted

COLLEGIUM PHARMACEUTICAL, INC short interest in 2021

In 2021, COLLEGIUM PHARMACEUTICAL, INC's disclosed short interest ran from 11.96% of shares outstanding on 15 Jan 2021 to 10.02% on 31 Dec 2021, a change of -1.94 percentage points. The year's high was 13.89% on 15 Nov 2021 and its low 9.53% on 31 Aug 2021, averaging 11.60% across 24 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 27.14 days on 15 Jul 2021. Full history: COLLEGIUM PHARMACEUTICAL, INC.

Cite this page
Plain
Wikipedia
BibTeX

By year: 2018 · 2019 · 2020 · 2021 · 2022 · 2023 · 2024 · 2025 · 2026

Aggregate net short position time series for COLLEGIUM PHARMACEUTICAL, INC in 2021

2021 in figures

Start of year
11.96% (15 Jan 2021)
End of year
10.02% (31 Dec 2021)
Change
-1.94 pp
High
13.89% (15 Nov 2021)
Low
9.53% (31 Aug 2021)
Average
11.60%
Highest days to cover
27.14 (15 Jul 2021)
SEC filings marked
8

Every report in 2021

COLLEGIUM PHARMACEUTICAL, INC short interest in 2021
SettlementShort interestDays to coverFilings since previous
15 Jan 202111.96%11.50
29 Jan 202112.28%11.26
12 Feb 202111.98%2.66
26 Feb 202113.05%9.6410-K filed, results (8-K)
15 Mar 202112.24%11.48
31 Mar 202112.23%14.61
15 Apr 202112.41%19.83
30 Apr 202112.32%25.81
14 May 202111.83%20.5210-Q filed, results (8-K)
28 May 202111.48%16.18
15 Jun 202112.28%18.75
30 Jun 202111.88%13.24
15 Jul 202112.09%27.14
30 Jul 202111.69%17.89
13 Aug 202110.19%6.9410-Q filed, results (8-K)
31 Aug 20219.53%9.36
15 Sep 202110.18%16.74
30 Sep 202110.44%13.13
15 Oct 202110.54%20.64
29 Oct 202110.81%14.80
15 Nov 202113.89%11.5910-Q filed, results (8-K)
30 Nov 202112.55%14.62
15 Dec 202110.63%12.29
31 Dec 202110.02%13.73

See also: COLLEGIUM PHARMACEUTICAL, INC's full history · most shorted US stocks of 2021 · today's US league.

About this data

US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.